HELXvsBBPETF Comparison
Franklin Genomic Advancements ETF (HELX) belongs to the BioTech & Genomics segment. Virtus LifeSci Biotech Products ETF (BBP) is part of the Tomorrow's Treatments segment. HELX's top 3 sector exposures are Health Care, Materials and Information Technology. In contrast, BBP's top sector exposures are Health Care, HELX is more expensive with a Total Expense Ratio (TER) of 0.5%, versus 0.34% for BBP. HELX is up 0.52% year-to-date (YTD) with +$2M in YTD flows. BBP performs better with 12.75% YTD performance, and +$30M in YTD flows. Run a side-by-side ETF comparison of HELX and BBP below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
HELX vs BBP performance and flow charts
Performance
Cumulative Flows
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | HELX BBP | +12.21%+7.09% | +13.29%+10.30% | +0.52%+12.75% | +33.94%+54.18% | +19.15%+65.37% | -21.05%+66.51% |
| Flows | HELX BBP | -+$4M | -+$26M | +$2M+$30M | +$8M+$42M | +$9M+$45M | +$14M+$38M |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | HELX BBP | +26.26%+28.71% | +21.06%+24.01% | +20.61%+24.02% | +23.62%+26.37% |
| Max drawdown | HELX BBP | -6.54%-7.49% | -17.89%-9.59% | -29.16%-25.54% | -58.50%-37.87% |
| Max drawdown duration | HELX BBP | 38d44d | 200d48d | 458d292d | 1745d760d |
HELX | BBP | |
Last sale 6/18/2026 at 1:30 PM | $36.49 | $90.01 |
| Previous close 06/18/2026 | $36.04 | $89.40 |
| Consolidated volume 06/18/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
HELX | BBP | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
HELX | BBP | |
|---|---|---|
| Last price | $36.49 | $90.01 |
| 1D performance | +1.24% | +0.68% |
| AuM | $23.71 M | $80.94 M |
| E/R | 0.5% | 0.34% |
HELX | BBP | |
|---|---|---|
| Management strategy | Active | Passive |
| Provider | Franklin Templeton | VIRTUS Investment Partners |
| Benchmark | - | LifeSci Biotechnology Products Index |
| N° of holdings | 50 | 55 |
| Asset class | - | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | February 25, 2020 | December 16, 2014 |
| ESG | No | No |
Countries
Sectors
Diversification
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
